PlGF and VEGF-A/PlGF Heterodimer are Crucial for Recruitment and Activation of Immune Cells During Choroid Neovascularization
Investigative Ophthalmology & Visual Science · 2024
DOI: 10.1167/iovs.65.8.12 ↗Kurz gefasst
Fachartikel in der Zeitschrift Investigative Ophthalmology & Visual Science, 2024. Verfasst von Valeria Tarallo und 6 weiteren Autor:innen. Beteiligte Einrichtung: Angiogenesis Lab, Institute of Genetics and Biophysics 'Adriano Buzzati-Traverso' - CNR, Naples, Italy. Hauptthemen laut MEDLINE: Choroidal Neovascularization, Microglia, Placenta Growth Factor, Vascular Endothelial Growth Factor A. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Purpose
Recruitment and activation of inflammatory cells, such as retinal microglia/macrophages, in the subretinal space contribute significantly to the pathogenesis of age-related macular degeneration (AMD). This study aims to explore the functional role of vascular endothelial growth factor (VEGF-A), placental growth factor (PlGF) and VEGF-A/PlGF heterodimer in immune homeostasis and activation during pathological laser-induced choroidal neovascularization (CNV).
Methods
To investigate these roles, we utilized the PlGF-DE knockin (KI) mouse model, which is the full functional knockout (KO) of PlGF. In this model, mice express a variant of PlGF, named PlGF-DE, that is unable to bind and activate VEGFR-1 but can still form heterodimer with VEGF-A.
Results
Our findings demonstrate that, although there is no difference in healthy conditions, PlGF-DE-KI mice exhibit decreased microglia reactivity and reduced recruitment of both microglia and monocyte-macrophages, compared to wild-type mice during laser-induced CNV. This impairment is associated with a reduction in VEGF receptor 1 (VEGFR-1) phosphorylation in the retinae of PlGF-DE-KI mice compared to C57Bl6/J mice. Corroborating these data, intravitreal delivery of PlGF or VEGF-A/PlGF heterodimer in PlGF-DE-KI mice rescued the immune cell response at the early phase of CNV compared to VEGF-A delivery.
Conclusions
In summary, our study suggests that targeting PlGF and the VEGF-A/PlGF heterodimer, thereby preventing VEGFR-1 activation, could represent a potential therapeutic approach for the management of inflammatory processes in diseases such as AMD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Angiogenesis Lab, Institute of Genetics and Biophysics 'Adriano Buzzati-Traverso' - CNR, Naples, Italy.
- BIOVIIIx srl, Via Alessandro Manzoni 1, Napoli, Italy.
- AnBition srl, Via Alessandro Manzoni 1, Napoli, Italy.
Zitieren
APA
Tarallo, V., Magliacane Trotta, S., Panico, S., D'Orsi, L., Mercadante, G., Cicatiello, V., & De Falco, S. (2024). PlGF and VEGF-A/PlGF Heterodimer are Crucial for Recruitment and Activation of Immune Cells During Choroid Neovascularization. Investigative Ophthalmology & Visual Science. https://doi.org/10.1167/iovs.65.8.12
Vancouver
Tarallo V, Magliacane Trotta S, Panico S, D'Orsi L, Mercadante G, Cicatiello V, et al. PlGF and VEGF-A/PlGF Heterodimer are Crucial for Recruitment and Activation of Immune Cells During Choroid Neovascularization. Investigative Ophthalmology & Visual Science. 2024. doi:10.1167/iovs.65.8.12
BibTeX
@article{Tarallo2024,
author = {Tarallo, Valeria and Magliacane Trotta, Sara and Panico, Sonia and D'Orsi, Luca and Mercadante, Grazia and Cicatiello, Valeria and De Falco, Sandro},
title = {PlGF and VEGF-A/PlGF Heterodimer are Crucial for Recruitment and Activation of Immune Cells During Choroid Neovascularization},
journal = {Investigative Ophthalmology & Visual Science},
year = {2024},
doi = {10.1167/iovs.65.8.12}
}
EUVIMED